HERON THERAPEUTICS, INC. /DE/ Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Heron Therapeutics, Inc. /De/ Operating Income (Loss) for the quarter ending June 30, 2024 was -$6.45M, a 84.8% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ Operating Income (Loss) for the twelve months ending June 30, 2024 was -$46.4M, a 66.3% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Operating Income (Loss) for 2023 was -$111M, a 36.7% increase from 2022.
  • Heron Therapeutics, Inc. /De/ annual Operating Income (Loss) for 2022 was -$175M, a 19.8% increase from 2021.
  • Heron Therapeutics, Inc. /De/ annual Operating Income (Loss) for 2021 was -$218M, a 4.53% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$46.4M -$6.45M +$36M +84.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$82.4M -$4.8M +$28.3M +85.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$111M -$10.2M +$10.1M +49.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$121M -$24.9M +$17M +40.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$138M -$42.4M +$7.1M +14.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$145M -$33.1M +$29.9M +47.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$175M -$20.4M +$33.2M +62% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$208M -$41.9M +$9.83M +19% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$218M -$49.5M +$11M +18.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$229M -$62.9M -$10.8M -20.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$218M -$53.5M +$7.76M +12.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$226M -$51.7M +$6.68M +11.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$232M -$60.5M -$4.72M -8.47% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$228M -$52.1M +$620K +1.18% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$228M -$61.3M -$1.93M -3.26% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 -$226M -$58.4M -$23.5M -67.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$203M -$55.7M -$3.97M -7.67% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$199M -$52.7M +$12M +18.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$211M -$59.4M -$8.05M -15.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$203M -$34.9M +$6.93M +16.6% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 -$210M -$51.8M -$12.9M -33.3% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 -$197M -$64.7M -$12.7M -24.4% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 -$184M -$51.3M +$10.6M +17.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$195M -$41.8M -$466K -1.13% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$194M -$38.9M +$3.2M +7.61% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$197M -$52M -$2.69M -5.46% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$195M -$61.9M -$15.1M -32.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$179M -$41.3M +$6.42M +13.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$186M -$42.1M +$1.01M +2.35% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$187M -$49.3M -$16M -48% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$171M -$46.8M -$15.7M -50.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 -$155M -$47.7M -$25.2M -112% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 -$130M -$43.1M -$20.1M -87.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$110M -$33.3M -$13M -63.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$96.9M -$31.1M -$11.6M -59.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 -$85.4M -$22.5M -$3.54M -18.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$81.8M -$23M -$4.22M -22.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$77.6M -$20.4M -$3.04M -17.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$74.6M -$19.5M -$5.66M -40.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 -$68.9M -$19M -$6.29M -49.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$62.6M -$18.8M -$3.58M -23.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$59M -$17.3M -$4.57M -35.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$54.5M -$13.8M -$5.2M -60.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 -$49.3M -$12.7M -$6.61M -109% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$42.6M -$15.2M -$10.8M -247% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 -$31.8M -$12.8M -$7.98M -167% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$23.8M -$8.63M -$4.51M -110% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 -$19.3M -$6.05M -$1.97M -48.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$17.4M -$4.38M -$2.84M -184% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$14.5M -$4.77M -$3.45M -263% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$11.1M -$4.12M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-07
Q3 2011 -$4.09M -$2.45M -150% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 -$1.54M +$2.16M +58.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$1.32M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$1.64M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$3.7M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.